铁酸盐治疗非透析性慢性病的缺铁性贫血:一项随机的第三期研究
Mei-Yi Wu1,2,3, Chin-Chan Lee4,5, Chien-Te Lee6,7
1Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan.
Kidney research and clinical practice
|January 20, 2026
概括
铁酸盐 (PBF-1681) 在台湾患者中有效治疗缺铁性贫血,这些患者患有非透析依赖的慢性病. 治疗表明了有利的安全性,显示出血红蛋白水平的显著改善.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 铁酸盐 (FC) 用于治疗非透析性慢性病 (NDD-CKD) 患者的缺铁性贫血 (IDA).
- 这项研究专门研究了FC的疗效和安全性,品牌为PBF-1681,在台湾的一群NDD-CKD患者中.
研究的目的:
- 评估铁酸盐 (PBF-1681) 在治疗非透析性慢性病 (NDD-CKD) 患者中缺铁性贫血 (IDA) 的疗效.
- 评估铁酸盐 (PBF-1681) 在这种特定患者队列中的安全性和耐受性.
主要方法:
- 一项为期16周的,双盲,安慰剂控制,随机的III期试验,涉及141名台湾NDD-CKD患者.
- 参与者被随机分配1:1接受PBF-1681或安慰剂,随后进行了为期8周的开放式延长阶段,所有人都接受了PBF-1681.
- 剂量从每天2g开始,根据血红蛋白和血清酸盐水平,可能升高至每天4g.
主要成果:
- 与安慰剂相比,PBF-1681组的血红蛋白显著增加 (0.62 ± 0.15 g/dL,p < 0.0001).与安慰剂相比,PBF-1681组的血红蛋白显著增加 (0.62 ± 0.15 g/dL,p < 0.0001).
- 二级终点,包括血红蛋白增加≥1.0g/dL和持续的血红蛋白水平的患者比例,也显著改善.
- 在与铁相关的参数,血清酸盐,完整的副甲状腺激素和FGF23水平 (p <0.05) 中观察到积极的变化.
- 最常见的与治疗相关的不良事件是胃肠道疾病.
结论:
- 铁酸盐 (PBF-1681) 是一种有效的治疗铁缺乏症贫血的台湾患者,非透析依赖的慢性病.
- 该研究证实了PBF-1681在该患者群体中具有良好的安全性.
- 这些发现支持使用PBF-1681来管理NDD-CKD患者的IDA.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
359
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
359
01:25Chronic Kidney Disease I: Introduction
596
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
596
01:24Chronic Kidney Disease II: Clinical Manifestations
574
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
574
01:18Chronic Kidney Disease IV: Nursing Management
330
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
330
01:25Peritoneal Dialysis III: Nursing Management
715
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
715
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.6K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.6K